Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11666 publications

Patient preferences for stages II-IV melanoma treatments in the UK: results from a cross-sectional study.

Patient preferences for stages II-IV melanoma treatments in the UK: results from a cross-sectional study.

Journal: Melanoma management
Published: October 18, 2025

Exploring Treatments for Hepatic Epithelioid Hemangioendothelioma: A Subsegmental Bland Embolization Case Series With Review.

Exploring Treatments for Hepatic Epithelioid Hemangioendothelioma: A Subsegmental Bland Embolization Case Series With Review.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: October 17, 2025

5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

Journal: Immunotherapy
Published: October 17, 2025

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431].

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431].

Journal: JTO clinical and research reports
Published: October 15, 2025

A Case of Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.

A Case of Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological Findings.

Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2025

Gastric Carcinoma: Diagnosis, Staging, and Treatment.

Gastric Carcinoma: Diagnosis, Staging, and Treatment.

Journal: Deutsches Arzteblatt international
Published: October 14, 2025

Immune checkpoint inhibitor-induced nephrotic syndrome: a pharmacovigilance analysis of 404 FAERS cases and literature case series.

Immune checkpoint inhibitor-induced nephrotic syndrome: a pharmacovigilance analysis of 404 FAERS cases and literature case series.

Journal: Renal failure
Published: October 14, 2025

Modelling and optimizing combination therapeutic strategies for KRAS- and EGFR-mutant lung cancer.

Modelling and optimizing combination therapeutic strategies for KRAS- and EGFR-mutant lung cancer.

Journal: Journal of bioinformatics and computational biology
Published: October 13, 2025

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Causes of Death Among Individuals With Lynch Syndrome in the Immunotherapy Era.

Journal: JCO precision oncology
Published: October 11, 2025

Updated 2025 French Guidelines for Renal Cell Carcinoma.

Updated 2025 French Guidelines for Renal Cell Carcinoma.

Journal: The French journal of urology
Published: October 10, 2025

FDA Approves Injectable Keytruda for Nearly 20 Cancers.

FDA Approves Injectable Keytruda for Nearly 20 Cancers.

Journal: JAMA
Published: October 10, 2025

Tsunami of approvals for immune checkpoint inhibitors in early setting of head and neck tumors.

Tsunami of approvals for immune checkpoint inhibitors in early setting of head and neck tumors.

Journal: Immunotherapy
Published: October 09, 2025
Showing 1-12 of 11,666

Last Updated: 10/31/2025